Metallo--lactamases (MBLs) are targets for medicinal chemistry as they mediate bacterial resistance to -lactam antibiotics. Electrospray-ionization mass spectrometry (ESI-MS) was used to study the inhibition by a set of mercaptocarboxylates of two representative MBLs with different optimal metal stoichiometries for catalysis. BcII is a dizinc MBL (Class B1), whilst the CphA MBL (Class B2) exhibits highest activity with a single zinc ion in the active site. Experimental parameters for the detection of the metallo-enzyme and the metallo-enzymeinhibitor complexes were evaluated and optimized. Following investigations on the stoichiometry of metal binding, the affinity of the inhibitors was investigated by measuring the relative abundance of the complex compared to the metalloprotein. The results for the BcII enzyme were in general agreement with solution assays and demonstrated that the inhibitors bind to the dizinc form of the BcII enzyme. The results for the CphA(Zn II ) complex unexpectedly revealed an increased affinity for the binding of a second metal ion in the presence of thiomandelic acid. The results demonstrate that direct ESI-MS analysis of enzyme:inhibitor complexes is a viable method for screening inhibitors and for the rapid assay of the enzyme:metal:inhibitor ratios. (J Am Soc Mass Spectrom 2006, 17, 1000 -1004) © 2006 American Society for Mass Spectrometry T he hydrolysis of -lactam antibiotics is employed by both Gram-positive and -negative bacteria to enable antibiotic resistance. -Lactamases may be divided into the serine and metallo--lactamase (MBL) classes. The MBLs can be further subdivided into three subclasses, B1, B2, and B3, on the basis of their structures and substrate specificity [1]. Subclasses B1 and B3 display a broad substrate selectivity profile, whereas the B2 enzymes are more selective for carbapenems [2,3]. MBLs utilize one or two zinc ions as a cofactor, but there is uncertainty as to whether one or two zinc ions are involved in catalysis in vivo [4,5]. The presence of a second zinc ion inhibits the B2 class enzymes noncompetitively but increases the rate of catalysis of enzymes from the other subclasses [6]. The substrate profile of the family, coupled with the different metal stoichiometries, poses a challenge for the design of clinically useful inhibitors. Mercaptocarboxylates have been identified as competitive inhibitors of the MBLs [7] and structures of the MBLs reveal that the thiol group of inhibitor is chelated by both zinc ions [8,9].The aim of this work was to investigate the utility of ESI-MS for the screening of MBL inhibitors, by direct analysis of enzyme:metal:inhibitor complexes. Precedents for the use of ESI-MS to directly investigate